Predictors of adalimumab drug survival in psoriasis differ by reason for discontinuation: long-term results from the Bio-CAPTURE registry
Author:
Affiliation:
1. Department of Dermatology; Radboud university medical center; Nijmegen the Netherlands
2. Department for Health Evidence; Radboud university medical center; Nijmegen the Netherlands
Funder
University Medical Center St Radboud Foundation
Publisher
Wiley
Subject
Infectious Diseases,Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.12636/fullpdf
Reference27 articles.
1. Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials;Reich;Br J Dermatol,2012
2. Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data;Rustin;Br J Dermatol,2012
3. Drug survival rates for tumour necrosis factor-alpha antagonists in psoriasis;Burden;Br J Dermatol,2011
4. Registry research in dermatology;Rustenbach;Hautarzt,2011
5. Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials;Garcia-Doval;Arch Dermatol,2012
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Comprehensive Review of the Factors Affecting the Redefinition of Therapeutic Use in Metropolitan Cities during the Emerging and Re-emerging Pandemics;Romanian Journal of Military Medicine;2024-09-01
2. Investigating EGFR, BRAF, and RAS Mutations in Oral and Cutaneous Squamous Cell Neoplasms: A Preliminary Report on Romanian Patients;Romanian Journal of Military Medicine;2024-09-01
3. Adjunctive Chinese medicine therapy reduces relapse of psoriasis vulgaris after discontinuation of biologics: a prospective registry-based cohort study;Journal of Dermatological Treatment;2024-05-20
4. Importance and prospects of studying survival of genetically engineered biological therapy for psoriasis in children;Medical alphabet;2022-05-18
5. Prevalence and characterization of treatment‐refractory psoriasis and super‐responders to biologic treatment: a nationwide study;Journal of the European Academy of Dermatology and Venereology;2022-04-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3